Summary
The polymorphism affecting codon 4311 of the apolipoprotein B gene (ApoB/4311) was investigated in a large case-control study in two French and one Northern Irish geographically defined populations. Cases were recruited 3 to 9 months after a myocardial infarction (MI) and controls were randomly selected from the population. The polymorphism was assessed using allele-specific oligonucleotides (ASO). The genotype frequencies of the ApoB/4311 polymorphism did not differ in Northern Ireland and France and were in Hardy-Weinberg equilibrium in all groups; strong associations with three other polymorphisms of the ApoB gene (XbaI, EcoRI, VNTR(34 repeats)) were observed and it was possible to identify highly sensitive and specific markers of the ApoB/4311 rare variant. Homozygotes for the ApoB 4311 rare variant were slightly less frequent in cases than in controls: 22 (4.4%) and 35 (6.7%) respectively (population adjusted χ2=3.3 P<0.07), especially in Belfast: 6 (3.1%) and 12 (7.6%), respectively (P<0.06). Several lipid and lipoprotein parameters were measured. Consistently among control groups, rare homozygotes had lower mean levels of ApoB (P<0.02), triglycerides (P<0.02), and lipoprotein particles containing ApoE and ApoB (LpE:B; P<0.001) and a higher mean level of lipoprotein particles containing ApoAI and not ApoAII (LpAI; P<0.02) than heterozygotes and frequent homozygotes combined. The strong association between the ApoB/4311 polymorphism and LpE:B was also observed in patients with MI. When present in the homozygous form, the ApoB/ 4311 Asn→Ser variant is associated with a lipoprotein profile that is apparently favourable.
Similar content being viewed by others
References
Alaupovic P (1972) Conceptual development of the classification system of plasma lipoproteins. Protides Biol Fluids Proc Colloq 19:9–19
Alaupovic P, Lee DM, McConathy WJ (1972) Studies on the composition and structure of plasma lipoproteins: distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta 260:689–707
Berg K (1979) Inherited lipoprotein variation and atherosclerotic disease. In: Scanu AM, Wissler RW, Getz GS (eds) The biochemistry of atherosclerosis. Dekker, New York, pp 419–490
Berg K, Hannes C, Dahlen G, Frick H, Krishan I (1976) Genetic variation in serum low density lipoproteins and lipid levels in man. Proc Natl Acad Sci USA 73:937–940
Berg K, Powell LM, Wallis SC, Pease R, Knott TJ, Scott J (1986) Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: assignment of the Ag locus. Proc Natl Acad Sci USA 83:7367–7370
Boerwinkle E, Chan L (1989) A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B gene directly typed by the polymerase chain reaction. Nucleic Acids Res 17:4003
Boerwinkle E, Xiong W, Fourest E, Chan L (1989) Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci USA 86:212–216
Breguet G, Bütler R, Bütler-Brunner E, Sanchez-Mazas A (1990) A worldwide population study of the Ag-system haplotypes, a genetic polymorphism of human low density lipoprotein. Am J Hum Genet 46:502–517
Cambien F (1989) Polymorphisme génétique des apolipoprotéines. Med Sci 5:379–388
Cambien F, Warnet J, Jacqueson A, Ducimetiere P, Richard JL, Claude JR (1987) Relation of parental history of early myocardial infarction to the level of apoprotein B in men. Circulation 76:266–271
Cambien F, Parra HJ, Arveiler D, Cambou JP, Evans AE, Bingham A, Douste-Blazy P, Ducimetiere P, Fruchart JC (1990) Lipoprotein particles in patients with myocardial infarction and controls (abstract). Circulation 82 [Suppl 3]:348
Davignon S, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21
Dunning AM, Renges HH, Xu CF, Peacock R, Brasseur R, Laxer G, Tikkanen MJ, Bütler R, Saha N, Hamsten A, Rosseneu M, Talmud P, Humphries SE (1992) Complete allelic association between two amino acid substitutions in apolipoprotein B and x/y group antigen. Am J Hum Genet 50:208–221
Fisher SG, Lerman LS (1983) DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondance with melting theory. Proc Natl Acad Sci USA 80:1579–1583
Gavish D, Brinton EA, Breslow JL (1989) Heritable allele-specific differences in amounts of ApoB and low-density lipoprotein in plasma. Science 244:72–76
Hasstedt SJ, Wu L, Williams RR (1987) Major locus inheritance of apolipoprotein B in Utah pedigrees. Genet Epidemiol 4:67–76
Hill WG (1975) Tests of association of gene frequencies at several loci in random mating diploid populations. Biometrics 31:881–888
Hobbs HH, Russel DW, Brown MS, Goldstein JL (1990) The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet 24:133–170
Innerarity TL, Mahley RW, Weisgraber KH, Bersot TB, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ (1990) Familial defective apolipoprotein B100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 31:1337–1348
Jenner K, Sidoli A, Ball M, Rodriguez JR, Pagani F, Giudici G, Vergani C, Mann J, Baralle FE, Shoulders CC (1989) Characterization of genetic markers in the 3′ end of the Apo B gene and their use in family and population studies. Atherosclerosis 60:39–49
Khoury MJ, Beaty TH, Dana Flanders W (1990) Epidemiologic approaches to the use of DNA markers in the search of disease susceptibility genes. Epidemiol Rev 12:41–54
Koren E, Puchois P, Alaupovic A, Fesmire J, Kandoussi A, Fruchtart JC (1987) Quantification of two different types of apolipoprotein AI containing lipoprotein particles in plasma by enzyme-linked differential-antibody immunosorbent assay. Clin Chem 33:38–43
Krul ES, Kinoshita M, Talmud P, Humphries SE, Turner S, Goldberg AC, Cook K, Boerwinkle E, Schonfeld G (1989) Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. Arteriosclerosis 9:856–868
Leitersdorf E, Van der Westhuyzen D, Coetzee GA, Hobbs HH (1989) Two common LDL receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest 84:954–961
Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH (1990) Common LDL receptor gene mutations in the French Canadian population. J Clin Invest 85:1014–1023
Leppert M, Breslow JL, Wu L, Hasstedt S, O'Connell P, Lathrop M, Williams RR, White R, Lalouel JM (1988) Inference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred. J Clin Invest 82:847–851
Ludwig HE, Blackhart BD, Pierotti VR, Caiata L, Fortier C, Knott T, Scott J (1987) DNA sequence of the human apolipoprotein B gene. DNA 6:363–372
Marcadet A, O'Connel P, Cohen D (1986) Standardized Southern Blot Workshop technique. In: Dupont BO (ed) Histocompatibility testing B, vol 1. Springer, New York Berlin Heidelberg
Navajas M, Laurent AM, Moreel JF, Ragab A, Cambou JP, Cuny G, Cambien F, Roizes G (1990) Detection by denaturing gradient gel electrophoresis of a new polymorphism in the apolipoprotein B gene. Hum Genet 86:91–93
Nei M (1987) Molecular evolutionary genetics. Columbia University Press, New York
Noll WW, Collins M (1987) Detection of human DNA polymorphisms with a simplified denaturing gradient gel electrophoresis technique. Proc Natl Acad Sci USA 84:3339–3343
Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC (1990) Differential electroimmunoassay of human LpAI lipoprotein particles on ready-to-use plates. Clin Chem 36:1431–1435
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Schuster H, Rauh G, Kormann B, Hepp T, Humphries S, Keller C, Wolfram G, Zöllner N (1990) Familial defective ApoB100: comparison with familial hypercholesterolemia in 18 cases detected in Munich. Arteriosclerosis 10:577–581
Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ (1989) Association between a specific apolipoprotein B mutation and familial defective ApoB100. Proc Natl Acad Sci USA 86:587–591
Talmud PJ, Barni N, Kessling AM, Carlsson P, Darnfors C, Bjursell G, Galton D, Wynn V, Kirk H, Hayden MR, Humphries S (1987) Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo and hyperlipidemic individuals. Atherosclerosis 67:81–89
Tiret L, Steinmetz J, Herbeth B, Visvikis S, Rakotovao R, Ducimetière P, Cambien F (1990) Familial resemblance of plasma apolipoprotein B: the Nancy study. Genet Epidemiol 7:187–197
Vu-Dac N, Mezdour H, Parra HJ, Luc G, Luyeye I, Fruchart JC (1989) A selective bi-site immunoenzymatic procedure for human Lp(a) lipoprotein quantification using monoclonal antibodies against apo(a) and ApoB. J Lipid Res 30:1437–1443
WHO MONICA Project Principal Investigators (1988) The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41:105–114
Young SG, Hubl ST, Smith RS, Claiborne F, Snyder SM, Terdiman JF (1989) Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B gene (B-46) N Engl J Med 320:1604–1610
Young SG, Hubl ST, Smith RS, Snyder SM, Terdiman JF (1990) Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-317). J Clin Invest 85:933–942
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moreel, J.F.R., Roizes, G., Evans, A.E. et al. The polymorphism ApoB/4311 in patients with myocardial infarction and controls: the ECTIM study. Hum Genet 89, 169–175 (1992). https://doi.org/10.1007/BF00217118
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00217118